Licensing Molecular Biology Regulations 
DrugBank
FEBRUARY 9, 2023
1 Present address: Functional Genomics and Metabolism Research Unit, Department of Biochemistry and Molecular Biology, University of Southern Denmark, Denmark. Summary: This paper discusses the use of a data science approach to synthesize current knowledge on the pharmacological implications of epigenetic regulation of gene expression.
Drug Target Review
FEBRUARY 28, 2024
Dr Rochlin earned a PhD in Molecular Biology and Genetics from Weill Cornell Medical College, conducting research at Sloan Kettering Institute, and a BA in Biology from the University of Pennsylvania. Normality sensing licenses local T cells for innate-like tissue surveillance. References Fichtner A, Ravens S, Prinz I.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
JANUARY 4, 2021
We believe our allogenic CAR-T platform is significantly stronger with chPD1 target licensed from Longwood University. relevant government policies and regulations relating to our industry. Amorette Barber of Longwood University will be heading up our chPD1 program. “We believe Prof. About Longwood University.
Codon
FEBRUARY 13, 2024
Phage-based products have been licensed for use as antibacterial agents in the sanitation , food production , and animal health industries. But one can only train a phage so much before it has changed, genetically, to the point where it is now considered a different phage to the one the regulator initially approved.
Codon
JULY 27, 2023
.” Wellcome Collection , London I wrapped up my series on “30 Days of Great Biology Papers.” ” This was a series of tweets in which I told brief stories behind seminal papers, mostly in molecular biology and biophysics. You can read all of them here. And it’s true, but only in an incomplete way.
Codon
JULY 27, 2023
.” Wellcome Collection , London I wrapped up my series on “30 Days of Great Biology Papers.” ” This was a series of tweets in which I told brief stories behind seminal papers, mostly in molecular biology and biophysics. You can read all of them here. And it’s true, but only in an incomplete way.
Drug Target Review
FEBRUARY 19, 2025
“Contrary to popular opinion, regulation is not a hurdle, but rather an enabler. If the data package (including safety) is well thought out and developed from the beginning, regulations can be a support to frame the development journey.
Expert insights. Personalized for you.
52 
Let's personalize your content